BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

508 related articles for article (PubMed ID: 28923911)

  • 1. How Ribosomes Translate Cancer.
    Sulima SO; Hofman IJF; De Keersmaecker K; Dinman JD
    Cancer Discov; 2017 Oct; 7(10):1069-1087. PubMed ID: 28923911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hallmarks of ribosomopathies.
    Kampen KR; Sulima SO; Vereecke S; De Keersmaecker K
    Nucleic Acids Res; 2020 Feb; 48(3):1013-1028. PubMed ID: 31350888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer Biogenesis in Ribosomopathies.
    Sulima SO; Kampen KR; De Keersmaecker K
    Cells; 2019 Mar; 8(3):. PubMed ID: 30862070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ribosome Biogenesis: A Central Player in Cancer Metastasis and Therapeutic Resistance.
    Elhamamsy AR; Metge BJ; Alsheikh HA; Shevde LA; Samant RS
    Cancer Res; 2022 Jul; 82(13):2344-2353. PubMed ID: 35303060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rare ribosomopathies: insights into mechanisms of cancer.
    Aspesi A; Ellis SR
    Nat Rev Cancer; 2019 Apr; 19(4):228-238. PubMed ID: 30670820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ribosomal proteins and human diseases: molecular mechanisms and targeted therapy.
    Kang J; Brajanovski N; Chan KT; Xuan J; Pearson RB; Sanij E
    Signal Transduct Target Ther; 2021 Aug; 6(1):323. PubMed ID: 34462428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth control and ribosomopathies.
    Teng T; Thomas G; Mercer CA
    Curr Opin Genet Dev; 2013 Feb; 23(1):63-71. PubMed ID: 23490481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probing the mechanisms underlying human diseases in making ribosomes.
    Farley KI; Baserga SJ
    Biochem Soc Trans; 2016 Aug; 44(4):1035-44. PubMed ID: 27528749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deregulation of ribosomal proteins in human cancers.
    El Khoury W; Nasr Z
    Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34873618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Translation defects in ribosomopathies.
    Boussaid I; Fontenay M
    Curr Opin Hematol; 2022 May; 29(3):119-125. PubMed ID: 35102070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ribosomopathies and the paradox of cellular hypo- to hyperproliferation.
    De Keersmaecker K; Sulima SO; Dinman JD
    Blood; 2015 Feb; 125(9):1377-82. PubMed ID: 25575543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ribosomopathies: how a common root can cause a tree of pathologies.
    Danilova N; Gazda HT
    Dis Model Mech; 2015 Sep; 8(9):1013-26. PubMed ID: 26398160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular etiology of defective nuclear and mitochondrial ribosome biogenesis: Clinical phenotypes and therapy.
    Jerome MS; Nanjappa DP; Chakraborty A; Chakrabarty S
    Biochimie; 2023 Apr; 207():122-136. PubMed ID: 36336106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ribosomal proteins as novel players in tumorigenesis.
    de Las Heras-Rubio A; Perucho L; Paciucci R; Vilardell J; LLeonart ME
    Cancer Metastasis Rev; 2014 Mar; 33(1):115-41. PubMed ID: 24375388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ribosome-Induced Cellular Multipotency, an Emerging Avenue in Cell Fate Reversal.
    Istiaq A; Ohta K
    Cells; 2021 Sep; 10(9):. PubMed ID: 34571922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ribosomopathies: New Therapeutic Perspectives.
    Orgebin E; Lamoureux F; Isidor B; Charrier C; Ory B; Lézot F; Baud'huin M
    Cells; 2020 Sep; 9(9):. PubMed ID: 32932838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ribosomal Proteins Control Tumor Suppressor Pathways in Response to Nucleolar Stress.
    Lessard F; Brakier-Gingras L; Ferbeyre G
    Bioessays; 2019 Mar; 41(3):e1800183. PubMed ID: 30706966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ribosomal heterogeneity - A new inroad for pharmacological innovation.
    Ford D
    Biochem Pharmacol; 2020 May; 175():113874. PubMed ID: 32105657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bypass of the pre-60S ribosomal quality control as a pathway to oncogenesis.
    Sulima SO; Patchett S; Advani VM; De Keersmaecker K; Johnson AW; Dinman JD
    Proc Natl Acad Sci U S A; 2014 Apr; 111(15):5640-5. PubMed ID: 24706786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nucleolar stress: From development to cancer.
    Lafita-Navarro MC; Conacci-Sorrell M
    Semin Cell Dev Biol; 2023 Feb; 136():64-74. PubMed ID: 35410715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.